Product
V114
Aliases
15-Valent Pneumococcal Conjugate, Placebo for V114, Pneumococcal 15-Valent Conjugate Vaccine, Vaccine (1 other aliases)
14 clinical trials
5 indications
Indication
Pneumococcal InfectionIndication
Pneumococcal InfectionsIndication
Acute Otitis MediaIndication
Pneumococcal VaccinesIndication
pneumococcal diseaseClinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Concomitant Administration of Either 23-Valent Pneumococcal Polysaccharide Vaccine or 15-Valent Pneumococcal Conjugate Vaccine With a Booster Dose of SARS-CoV-2 mRNA Vaccine in Healthy Adults 50 Years of Age or Older.Status: Completed, Estimated PCD: 2023-02-21
Clinical trial
A Phase I, Double-Blind, Randomized, Multicenter Trial of the Safety,Tolerability, and Immunogenicity of V114 in Healthy Japanese InfantsStatus: Completed, Estimated PCD: 2020-06-24
Clinical trial
A Study of V114 and Acute Otitis Media in Children (PNEU-ERA)Status: Active (not recruiting), Estimated PCD: 2025-06-05
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Catch-up Vaccination Regimens of V114 in Healthy Infants, Children, and Adolescents (PNEU-PLAN)Status: Completed, Estimated PCD: 2020-12-09
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese InfantsStatus: Completed, Estimated PCD: 2021-12-01
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active-comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (PNEU-PED-EU-1)Status: Completed, Estimated PCD: 2021-08-05
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4-dose Regimen of V114 in Healthy Infants (PNEU-PED)Status: Completed, Estimated PCD: 2021-05-24
Clinical trial
A Phase 3, Randomized, Double-blind, Active Comparator-controlled, Multicenter Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Recipients of Allogeneic Hematopoietic Stem Cell Transplant (PNEU-STEM)Status: Completed, Estimated PCD: 2021-11-04
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety and Tolerability of V114 in Healthy Infants (PNEU-LINK)Status: Completed, Estimated PCD: 2021-03-26
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active-comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2)Status: Completed, Estimated PCD: 2021-10-29
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ With Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)Status: Completed, Estimated PCD: 2020-12-14
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX™23 Eight Weeks Later in Children Infected With Human Immunodeficiency Virus (HIV) (PNEU-WAY PED)Status: Completed, Estimated PCD: 2021-05-03
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (PNEU-FLU)Status: Completed, Estimated PCD: 2019-06-24
Clinical trial
A Phase 3, Single-Arm, Open-label Clinical Study to Evaluate the Safety and Immunogenicity of 4 Doses of V114 Administered to Healthy Infants in South Korea.Status: Completed, Estimated PCD: 2022-11-04